DOI:10.2214/AJR.05.0492
AJR 2006; 187:1309-1311
© American Roentgen Ray Society
Incidental Pheochromocytoma Mimicking Adrenal Adenoma Because of Rapid Contrast Enhancement Loss
John K. Yoon1,
Erick M. Remer1 and
Brian R. Herts1
1 All authors: Department of Radiology, Cleveland Clinic Foundation, 9500 Euclid
Ave., Cleveland, OH 44195.
Received March 20, 2005;
accepted after revision April 26, 2005.
Address correspondence to E. M. Remer
(remere1{at}ccf.org).
Keywords: adenoma adrenal gland Barrett's esophagus CT MRI nonadenoma PET/CT pheochromocytoma
Introduction
The characterization of adrenal masses using noninvasive imaging has been
the focus of much interest, with the goal of easily differentiating between
benign and malignant lesions. A large body of literature exists on the subject
of characterizing adrenal lesions found during the staging of patients with
known extraadrenal primary malignancy. Signal loss on opposed-phase
gradient-echo MR images compared with in-phase images and mean attenuation
values of less than 10 H on unenhanced CT are both specific for
differentiating adenomas from nonadenomas. Each method exploits the abundance
of intracytoplasmic fat typically present in adenomas. Another well-studied
characteristic of adenomas is their relatively rapid enhancement and washout
on delayed contrast-enhanced images when compared with nonadenomas
[1-3].
A recent study [4] suggests
that the enhancement loss in pheochromocytomas and adrenocortical carcinomas
is similar to that seen in adrenal metastases but is significantly less than
that seen in adrenal adenomas, so an absolute washout 10 minutes after
contrast medium injection of greater than 50% is highly specific for adenomas.
We present a pathologically proven case of an incidental adrenal
pheochromocytoma with an absolute contrast medium washout of 72%.
Case Report
A 50-year-old man presented 9 years ago with a complaint of heartburn and
was diagnosed with gastroesophageal reflux disease and Barrett's esophagus. He
underwent regular surveillance with annual or biannual
esophagogastroduodenoscopy, and a recent such examination identified
high-grade dysplasia in a distal esophageal nodule. Contrast-enhanced CT of
the chest, abdomen, and pelvis showed a 2-cm incidental right adrenal nodule.
A PET/CT examination, performed with 11.1 mCi (410.7 MBq) 18F-FDG
IV, showed increased 18F-FDG uptake (with a standardized uptake
value of 4.9) in the right adrenal nodule
(Fig. 1A), but not in the
esophagus. A differential diagnosis of metastatic disease, primary neoplasm
such as pheochromocytoma, or benign cause was given.

View larger version (119K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1A 50-year-old man with Barrett's esophagus and esophageal
dysplasia on biopsy undergoing staging before esophagectomy.
18F-FDG coronal PET image shows focal, marked uptake in right
suprarenal region (arrow). Uptake is also present in urinary tract
and heart.
|
|
Adrenal CT was then performed, with unenhanced, 60-second enhanced, and
15-minute delayed imaging. All scans were obtained at 0.75-mm collimation, 120
kV, and 200 mAs (Sensation 16, Siemens Medical Solutions). Images were
reconstructed at a 3-mm slice thickness at 3-mm intervals and reviewed on a
PACS workstation (MV1000, Siemens Medical Solutions). The right adrenal nodule
measured 2.0 x 1.9 cm in maximum axial dimensions. Region of interest
measured 37 H on the unenhanced images
(Fig. 1B), 127 H on the
60-second contrast-enhanced images, and 62 H
(Fig. 1C) on the 15-minute
delayed images (Fig. 1D),
representing 72% absolute contrast enhancement washout. This is calculated as
follows:
where E is the enhanced attenuation value, D is the delayed
enhanced value, and U is the unenhanced value
[5].

View larger version (139K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1B 50-year-old man with Barrett's esophagus and esophageal
dysplasia on biopsy undergoing staging before esophagectomy. Unenhanced CT
shows 2-cm right adrenal nodule. Region of interest (circle) shows
mean attenuation of 37 H.
|
|

View larger version (143K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1C 50-year-old man with Barrett's esophagus and esophageal
dysplasia on biopsy undergoing staging before esophagectomy. Contrast-enhanced
CT image obtained 60 seconds after contrast administration shows region of
interest (circle) with enhancement to 127 H.
|
|

View larger version (138K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1D 50-year-old man with Barrett's esophagus and esophageal
dysplasia on biopsy undergoing staging before esophagectomy. Contrast-enhanced
CT image obtained 15 minutes after contrast administration shows region of
interest (circle) with washout to 62 H.
|
|
The patient denied headaches, palpitations, shortness of breath, and
diaphoresis. Blood pressure was 142 over 90 mm Hg; the patient was being
treated with antihypertensive medication, Norvasc (amlodipine besylate,
Pfizer), 5 mg orally per day, and he had no evidence of episodic hypertension.
A biochemical profile performed 1 month later revealed elevated 24-hour
urinary metanephrine of 1,087 µg (normal range, 52-341 µg) and 24-hour
urinary normetanephrine of 1,069 µg (normal range, 88-444 µg). The
urinary vanillylmandelic acid was at the upper limit of normal, measuring 4.0
mg/g creatinine. Urinary aldosterone and cortisol levels were also normal (18
µg/24 h and 64.1 µg/24 h, respectively).
The patient underwent a laparoscopic right adrenalectomy 6 weeks later, and
the diagnosis of right adrenal pheochromocytoma was pathologically confirmed.
The patient subsequently had an esophagectomy, and the pathology results
confirmed adenocarcinoma within Barrett's mucosa with high-grade
dysplasia.
Discussion
Although adrenal masses are common and pheochromocytomas are considered
rare, the true incidence of pheochromocytoma is unknown
[6]. A retrospective study from
the Mayo Clinic reported that a diagnosis of pheochromocytoma was made at
autopsy in 45% of patients [7].
Although it has long been thought that approximately 10% of pheochromocytomas
are incidental, several series suggest that more than 50% of pheochromocytomas
may be discovered incidentally
[8-10].
It is generally accepted that the diagnosis of an adrenal adenoma in the
setting of a known primary malignancy can be noninvasively confirmed in most
cases with both inphase and opposed-phase MRI or through a combination of
unenhanced and contrast-enhanced washout CT characteristics. The literature is
still emerging as to the best approach to incidental adrenal masses in
asymptomatic patients without a known primary cancer. This is because, in most
of the existing reports, discriminating adenomas from nonadenomas has been
based primarily on series of adenoma and adrenal metastases. In one series,
Szolar and Kammerhuber [11]
included six pheochromocytomas in the nonadenoma group, and all six showed
delayed contrast enhancement and percentage of contrast enhancement loss
values in the range of nonadenoma values. Szolar et al.
[4] reported 100% sensitivity
and specificity for the diagnosis of adrenal adenomas compared with both
adrenocortical carcinomas and pheochromocytomas using a threshold value of
greater than 50% for absolute contrast enhancement loss and 40% for relative
contrast enhancement loss. This retrospective study of 67 patients with 73
adrenal masses included 17 pheochromocytomas. Regarding the high specificity,
however, the authors note that their study may not have had enough statistical
power. Our case of pheochromocytoma with 72% washout reinforces that further
study is needed.
Our technique differs from that of Szolar et al.
[4] in that we performed
delayed imaging after 15 minutes rather than after 10 minutes. This might in
part account for a higher percentage of washout in our patient than was shown
in pheochromocytomas in their series. In 166 adrenal masses imaged by Caoili
et al. [12], a single
pheochromocytoma had washout in excess of 60% at 15 minutes. Also, two
pheochromocytoma cases have been reported with both absolute and relative
attenuation washout of greater than 60% at 10 minutes by Blake et al.
[13]. Unlike our patient,
these two patients were symptomatic. As suggested by Szolar et al., all
pheochromocytomas may not behave like those in their series.
The only region of increased 18F-FDG metabolism on the PET study
was in the right adrenal gland and not in the esophageal adenocarcinoma.
Fluorine-18 FDG has been previously described as accumulating in
pheochromocytoma in seven (58%) of 12 benign lesions and in 14 (82%) of 17
malignant lesions [14].
Perhaps PET/CT can play a role in detecting occult pheochromocytoma.
This case of an incidental pheochromocytoma showing contrast medium washout
greater than 50% on delayed imaging reiterates the importance of performing a
biochemical profile in any patient with an incidentally discovered adrenal
mass, regardless of clinical signs and symptoms. It also suggests the need for
further studies evaluating the delayed contrast-enhanced CT features of masses
other than adenomas and metastases because this patient would have been
misdiagnosed using the recently reported criteria.
References
- Korobkin M, Brodeur FJ, Francis IR, et al. CT time-attenuation
washout curves of adrenal adenomas and nonadenomas.
AJR 1998; 170:747
-752[Abstract/Free Full Text]
- Pena CS, Boland GW, Hahn PF, Lee MJ, Mueller PR. Characterization
of indeterminate lipid-poor adrenal masses: use of washout characteristics at
contrast enhanced CT. Radiology 2000;217
: 798-802[Abstract/Free Full Text]
- Szolar DH, Kammerhuber FH. Quantitative CT evaluation of adrenal
gland masses: a step forward in the differentiation between adenomas and
nonadenomas. Radiology 1997;202
: 517-521[Abstract/Free Full Text]
- Szolar DH, Korobkin M, Reittner P, et al. Adrenocortical carcinomas
and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed
contrast-enhanced CT. Radiology 2005;234
: 479-485[Abstract/Free Full Text]
- Dunnick NR, Korobkin M. Imaging of adrenal incidentalomas: current
status AJR 2002;179
: 559-568[Free Full Text]
- Francis IR, Korobkin M. Pheochromocytoma. Radiol Clin
North Am 1996; 34:1101
-1112[Medline]
- Beard CM, Sheps SG, Kurland LT. Occurrence of pheochromocytoma in
Rochester, Minnesota, 1950 through 1979. Mayo Clin
Proc 1983; 58:802
-804[Medline]
- Miyajima A, Nakashima J, Baba S, et al. Clinical experience with
incidentally discovered pheochromocytoma. J Urol1997; 157:1566
-1568[CrossRef][Medline]
- Cheah WK, Clark OH, Horn JK, Siperstein AE, Duh Q-Y. Laparoscopic
adrenalectomy for pheochromocytoma. World J Surg2002; 26:1048
-1051[CrossRef][Medline]
- Motta GA, Remer EM, Herts BR, Gill IS, Hamrahian AH. Comparison of
CT findings in symptomatic and incidentally discovered pheochromocytomas.
AJR 2005; 185:684
-688[Abstract/Free Full Text]
- Szolar DH, Kammerhuber FH. Adrenal adenomas and nonadenomas:
assessment of washout at delayed contrast-enhanced CT.
Radiology 1998;207
: 369-375[Abstract/Free Full Text]
- Caoili EM, Korobkin M, Francis IR, et al. Adrenal masses:
characterization with combined unenhanced and delayed enhanced CT.
Radiology 2002;222
: 629-633[Abstract/Free Full Text]
- Blake MA, Krishnamoorthy SK, Boland GW, et al. Low-density
pheochromocytoma on CT: a mimicker of adrenal adenoma.
AJR 2003; 181:1663
-1668[Abstract/Free Full Text]
- Shulkin BL, Thompson NW, Shapiro B, Francis IR, Sisson JC.
Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET.
Radiology 1999;212
: 35-41[Abstract/Free Full Text]

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. T. Johnson, K. M. Horton, and E. K. Fishman
Adrenal Mass Imaging with Multidetector CT: Pathologic Conditions, Pearls, and Pitfalls
RadioGraphics,
September 1, 2009;
29(5):
1333 - 1351.
[Abstract]
[Full Text]
[PDF]
|
 |
|